Phospholutions, the State College, Pa.-based fertilizer technology company, said it would be entering its next phase of adoption after a year of commercial growth.
The company said it has surpassed one million acres of commercial use for its RhizoSorb, Phospholutions’ patented fertilizer technology, which improves phosphorus use efficiency by helping crops access more of the applied nutrient. The company said its growth after one year reflects an increasing demand for agriculture technologies that deliver results in the field. Additionally, phosphorus has been designated a U.S. critical mineral, increasing demand for their product as phosphorus supply remains constrained and its pricing volatility is on the rise.
“This past year marked a step-change for Phospholutions, from proving performance to scaling adoption,” Hunter Swisher, CEO and founder of Phospholutions, said. “We’ve validated RhizoSorb across crops and geographies, strengthened our manufacturing foundation, and expanded market access in the U.S. and internationally. Heading into the 2026 season, our focus is execution at scale by expanding availability through our partners and delivering measurable value for growers, acre by acre.”
The company said more than one million acres have been treated with RhizoSorb in commercial crop production, and that the product has demonstrated repeatable, on-farm performance at scale. More than 700 trials across crops and five years of field-scale on-farm data across 18 states, has shown statistically significant corn yield gains averaging 1.6 increase at 50 percent reduction in phosphorus.
Additionally, the company said over the past year it has secured three phosphate manufacturing partners to support supply and production capacity, advanced regulatory progress for its product and fortified its global intellectual property footprint with two newly issued U.S. patents. Internationally, the company has expanded into Canada and Brazil and started market development and trial sites across 13 countries in Latin America, with and additional six global markets already underway.
“We believe that Phospholutions has moved from a promising, innovative company to having scalable execution,” Suyash Bulchandani, Vice President of Conti Ventures, Continental Grain Company, an investor in Phospholutions, said. “The company has demonstrated performance at commercial scale and strengthened production capability to meet demand, and we believe it continues to build defensibility through intellectual property and strong execution. We’re looking forward to continuing to support Phospholutions as it enters its next stage of growth and expands access for growers across markets.”